Physician profile
John D Day
NPI 1811965122
$312,722.81
in general payments reported to CMS, 2019-2025
20 companies · $64K in 2025
The $64K reported for 2025 was more than what 96% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $34K · 2021: $17K · 2022: $34K · 2023: $19K · 2024: $82K · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $80K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $59K · Travel and Lodging: $16K · Food and Beverage: $8,887 · Education: $27.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $80,437.50 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $58,750.00 |
| Travel and Lodging | $15,866.61 |
| Food and Beverage | $8,887.43 |
| Education | $27.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $175,920.56 | 2019-2025 | Farapulse, General - Therapies, Accolade Sr |
| Abbott Laboratories | $126,264.76 | 2019-2025 | Ensite, Tacticath Ablation Catheter, Sensor Enabled, Thoratec Heartmate 3 Lvas Implant Kit |
| Philips North America LLC | $7,007.97 | 2020-2024 | (5044) Mcot |
| Medtronic Vascular, INC. | $2,290.42 | 2019 | |
| Novartis Pharmaceuticals Corporation | $336.77 | 2021-2025 | |
| Pfizer INC. | $226.65 | 2021-2025 | |
| Medtronic, INC. | $151.32 | 2022-2024 | Azure Xt Dr Mri Surescan, Micra, Linq II |
| Janssen Pharmaceuticals, INC | $131.82 | 2021-2022 | |
| Amgen INC. | $85.78 | 2023-2024 | Repatha |
| Amarin Pharma, INC. | $63.88 | 2021 | |
| Becton, Dickinson and Company | $44.62 | 2025 | Hemosphere |
| Kiniksa Pharmaceuticals, Ltd. | $42.34 | 2022-2023 | Arcalyst |
| Inspire Medical Systems, INC. | $26.85 | 2023 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $26.05 | 2021-2023 | Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.10 | 2025 | Lifevest |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiva Medical, INC. | $18.55 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Merck Sharp & Dohme LLC | $16.71 | 2021 | |
| Recor Medical INC | $16.59 | 2024 | Paradise Renal Denervation System |
| Atricure, INC. | $14.56 | 2022 | |
| Daiichi Sankyo INC. | $14.51 | 2023 | Injectafer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Day listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.